gebhart/patrepeval huggingface dataset:
A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study. (2004)

Olanzapine had a greater impact on patients' weight than aripiprazole. Significant differences in favor of aripiprazole were also observed in the effects of therapy on plasma lipid profile. Both treatment groups achieved comparable clinically meaningful improvements on efficacy measures. The observed effects on weight and lipids indicate a potentially lower metabolic and cardiovascular risk in patients treated with aripiprazole compared with those treated with olanzapine.
Agonist-dependent Dissociation of Human Somatostatin Receptor 2 Dimers (2004)

G-protein-coupled receptors (GPCRs) represent the largest and most diverse family of cell surface receptors. Several GPCRs have been documented to dimerize with resulting changes in pharmacology and signaling. We have previously reported, by means of photobleaching fluorescence resonance energy transfer (pbFRET) microscopy and fluorescence correlation spectroscopic analysis in live cells, that human somatostatin receptor (hSSTR) 5 could both homodimerize and heterodimerize with hSSTR1 in the presence of the agonist SST-14. By contrast, hSSTR1 remained monomeric when expressed alone regardless of agonist exposure in live cells. However, the effect of the agonist on other hSSTR members remains unknown. Using pbFRET microscopy and Western blot, we provide evidence for agonist-dependent dissociation of self-associated hSSTR2 stably expressed in CHO-K1 and HEK-293 cells. Furthermore, the dissociation of the hSSTR2 dimer occurred in a concentration-dependent manner. Moreover, blocking receptor dissociation using a cross-linker agent perturbed receptor trafficking. Taking these data together, we suggest that the process of GPCR dimerization may operate differently, even among members of the same family, and that receptor dissociation as well as dimerization may be important steps for receptor dynamics.
Absence of long‐term analgesic effect from a short‐term S‐ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo‐controlled trial (2011)

To assess the analgesic efficacy of the N-methyl-D-aspartate receptor antagonist S(+)-ketamine on fibromyalgia pain, the authors performed a randomized double blind, active placebo-controlled trial. Twenty-four fibromyalgia patients were randomized to receive a 30-min intravenous infusion with S(+)-ketamine (total dose 0.5mg/kg, n=12) or the active placebo, midazolam (5mg, n=12). Visual Analogue Pain Scores (VAS) and ketamine plasma samples were obtained for 2.5-h following termination of treatment; pain scores derived from the fibromyalgia impact questionnaire (FIQ) were collected weekly during an 8-week follow-up. Fifteen min after termination of infusion the number of patients showing a reduction in pain scores >50% was 8 vs. 3 (P<0.05), at t=180min 6 vs. 2 (ns), at the end of week-1 2 vs. 0 (ns) and at end of week-8 2 vs. 2 in the ketamine and midazolam groups, respectively. Ketamine effect on VAS closely followed ketamine plasma concentrations. For VAS and FIQ scores no significant differences in treatment effects were observed in the 2.5-h following infusion or during the 8-week follow-up. Side effects as measured by the Bowdle questionnaire (which scores for 13 separate psychedelic symptoms) were mild to moderate in both study groups and declined rapidly, indicating adequate blinding of treatments. Efficacy of ketamine was limited and restricted in duration to its pharmacokinetics. The authors argue that a short-term infusion of ketamine is insufficient to induce long-term analgesic effects in fibromyalgia patients.
Electroporation microchips forin vitrogene transfection (2001)

A detailed study of a novel electroporation (EP) microchip for in vitro gene transfection has been conducted. Electroporation is a technique with which DNA molecules can be delivered into cells in a chamber using high electric field pulses. Compared to a commercial electroporator, the EP microchip can attain the necessary electric field for the electroporation process but takes advantage of a much lower required voltage. The EP microchip overcomes the potential risk of using a high voltage, which is the drawback of current electroporation technology. Furthermore, the advantages of this EP microchip are the use of a very small amount of cells and genes, a very low applied voltage, a simple power supply and a much simpler cell preparation process. Any of these advantages are better than, or cannot be found in, a commercial electroporator.
Atomic Layer Deposition of TaN, NbN, and MoN Films for Cu Metallizations (2005)

Transition metal nitrides, metal silicides, and metal-silicon-nitrides are considered the most promising diffusion barrier materials for next generation ultra large scale integration (ULSI) microelectronics. The semiconductor industry has long used Ti, Ta, and W based materials, and their material properties have been very well studied. Recently, tantalum-based materials have been attracting particular interest. The barrier properties of materials based on other transition metals have been little studied. In this work, tantalum nitride films were deposited, with four new reducing agents used to reduce tantalum and obtain the desired TaN phase. As well, the deposition of niobium and molybdenum nitride films was investigated. All films were deposited by the atomic layer deposition (ALD) method, which ensures excellent conformality and large area uniformity of the films. The problem in depositing TaN films by ALD is that in volatile tantalum precursors the tantalum usually exists in oxidation state +V which is difficult to reduce to the +III state needed in cubic TaN. The new reducing agents examined in this study were trimethylaluminum (TMA), tert-butylamine (BuNH2), allylamine (allylNH2), and tris(dimethylamino)silane (TDMAS). In addition to reducing tantalum, TMA also acted as a carbon and aluminum source, BuNH2 and allylNH2 as nitrogen sources, and TDMAS as a silicon precursor. ALD of niobium nitride and molybdenum nitride films was studied at lower temperatures than reported earlier. Both NbNx and MoNx films were deposited from the corresponding metal chloride precursors (NbCl5 and MoCl5, respectively) using ammonia as nitrogen source. No additional reducing agent was required. The deposition parameters, compositions, crystallinity, and electrical properties were studied for all deposited films. Barrier characteristics were investigated for Ta(Al)N(C), NbNx, and MoNx films. The work function values were measured for Ta(Si)N films deposited at two different temperatures.
Virus induction of NF-kappa B/Rel proteins and type I interferon gene expression in myelomonoblastic cells. (1994)

The correlation between virus induced NF-kappa B DNA binding activity and interferon gene expression was examined in the myelomonoblastic PLB-985 cell line. Previous studies have shown that chronic HIV-1 infection of PLB-985 cells (PLB-IIIB) leads to the selection of cells with a more differentiated monocytic phenotype and with constitutive NF-kappa B DNA-binding activity. In this report we demonstrate that the kinetics of HIV-1 and Sendai virus infection of PLB-985 cells directly correlates with induction of NF-kappa B DNA binding activity. Based on UV cross-linking and immunoprecipitation analysis, p50, the strong transcriptional activator p65 and c-Rel represent the major constituents of this NF-kappa B DNA-binding activity. We also demonstrate an alteration in the kinetics of type I IFN gene transcription following secondary Sendai virus infection of PLB-IIIB cells compared to PLB-985. The results of our studies suggest that HIV infected individuals may respond differently to secondary viral or bacterial infections by augmenting the synthesis of NF-kappa B regulated immune response modifiers, which could alter the onset or progression of AIDS.
Characterization of Neutral Proteinases from Alzheimer‐Affected and Control Brain Specimens: Identification of Calcium‐Dependent Metalloproteinases from the Hippocampus (1992)

Three neutral proteinases from human hippocampal tissue have been identified and partially characterized using substrate gel electrophoresis. The proteinases showed activity when gelatin was used as the substrate, but had no detectable activity against casein. Based on the results of inhibition studies and the calcium requirements, it was concluded that the activities were due to calcium-dependent metalloproteinases. The apparent molecular weights were 130,000 (MP-130), 100,000 (MP-100), and 70,000 (MP-70). Half-maximal activities were observed with 20 microM Ca2+ for MP-130, 40 microM Ca2+ for MP-100, and 800 microM Ca2+ for MP-70. In the presence of Ca2+, Zn2+ reestablished the activities of the three metalloproteinases at a lower concentration than did either Co2+ or Mn2+. One millimolar Al3+ inhibited 67% of the MP-70 activity, but did not affect the MP-100 and MP-130 activities. An analysis of Alzheimer-affected hippocampal and control samples showed that the specific activity (in units per milligram of sodium dodecyl sulfate-soluble protein) of MP-70 varied less than the activities of MP-100 and MP-130 between the two groups. Although p-amino-phenylmercuric acetate (p-APMA) increased the activities of MP-70 by 70% in both groups of specimens, the resulting activities from Alzheimer samples were greater than those from control samples (p less than 0.01). A wide range of MP-100 specific activity was observed in both groups, and its mean activity was higher in Alzheimer-affected samples (p less than 0.05). Treatment with p-APMA increased the activity of MP-100 only 25% in both groups of tissue samples. MP-130 activity was detected predominantly in Alzheimer-affected hippocampal specimens, and treatment with p-APMA failed to increase its activity in both the control and the Alzheimer-affected specimens. The results demonstrate an elevated level of metalloproteinase activities, capable of degrading tissue matrix components, in the hippocampus from postmortem Alzheimer patients.
A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis (1987)

Cop 1 is a random polymer (molecular weight, 14,000 to 23,000) simulating myelin basic protein. It is synthesized by polymerizing L-alanine, L-glutamic acid, L-lysine, and L-tyrosine. It suppresses but does not induce experimental allergic encephalomyelitis, an animal model of multiple sclerosis. It is not toxic in animals. In a double-blind, randomized, placebo-controlled pilot trial, we studied 50 patients with the exacerbating-remitting form of multiple sclerosis, who self-injected either 20 mg of Cop 1 dissolved in 1 ml of saline or saline alone daily for two years. Six of 23 patients in the placebo group (26 percent) and 14 of 25 patients in the Cop 1 group (56 percent) had no exacerbations (P = 0.045). There were 62 exacerbations in the placebo group and 16 in the Cop 1 group, yielding two-year averages of 2.7 and 0.6 per patient, respectively. Among patients who were less disabled on entry (Kurtzke disability score, 0 to 2), there were 2.7 exacerbations in the placebo group and 0.3 in the Cop 1 group over two years. Among patients who were more affected (Kurtzke disability score, 3 to 6), there was an average of 2.7 exacerbations in the placebo group and 1.0 in the Cop 1 group. Over two years, less disabled patients taking Cop 1 improved an average of 0.5 Kurtzke units; those taking placebo worsened an average of 1.2 Kurtzke units. More disabled patients worsened by 0.3 (Cop 1 group) and 0.4 (placebo group) unit. Irritation at injection sites and rare, transient vasomotor responses were observed as side effects. These results suggest that Cop 1 may be beneficial in patients with the exacerbating-remitting form of multiple sclerosis, but we emphasize that the study is a preliminary one and our data require confirmation by a more extensive clinical trial.
Regulation of HIV Production by Blood Mononuclear Cells from HIV-Infected Donors: I. Lack of Correlation Between HIV-1 Production and T Cell Activation (1993)

The relationship between production of HIV-1 by peripheral blood mononuclear cells (PBMCs) from HIV-1-infected donors and the level of T cell activation by various stimuli was examined. Stimulation of PBMCs with soluble anti-CD3 antibody or staphylococcal enterotoxin/superantigen (SAg) was found to be 100-1000 times more effective at inducing production of HIV-1 than was stimulation with immobilized anti-CD3 or various other T cell activating agents. However, proliferation of CD4+ T cells and lymphokine production following stimulation with soluble anti-CD3 were less than with immobilized anti-CD3. To determine whether immobilized anti-CD3 stimulated cells may produce a factor(s) that suppresses HIV production, dual-chamber coculture experiments were performed in which soluble and immobilized anti-CD3-stimulated CD8-depleted PBMCs were separated by porous membranes. Stimulation of cells by immobilized anti-CD3 suppressed HIV-1 production by soluble anti-CD3-stimulated cells in the inner chamber, suggesting that diffusible factor(s) are involved in suppressing HIV-1 production. Experiments in which exogenous cytokines were added to cells stimulated with soluble anti-CD3 did not reveal the suppressive factor(s) produced; however, IL-7 was found to markedly increase HIV-1 production. Both T cells and monocytes were found to be required for soluble anti-CD3 to induce high levels of HIV-1 production, suggesting a role for adhesion molecules. Our results thus show that (1) soluble anti-CD3 is a powerful stimulus for HIV production, (2) there is not an absolute correlation between the level of HIV-1 production and T cell activation following stimulation of PBMCs with T cell activating agents, (3) immobilized anti-CD3 stimulation produces a factor that decreases HIV replication, and (4) T cell monocyte interactions are important for production of HIV-1 following stimulation with soluble anti-CD3.
1-Methyl-7-halo-2-naphthalenecarboxylic Acid Derivatives (1964)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXT1-Methyl-7-halo-2-naphthalenecarboxylic Acid DerivativesRodger W. Griffin Jr., Jerald D. Gass, Martin A. Berwick, and Richard S. ShulmanCite this: J. Org. Chem. 1964, 29, 8, 2109–2116Publication Date (Print):August 1, 1964Publication History Published online1 May 2002Published inissue 1 August 1964https://doi.org/10.1021/jo01031a001Request reuse permissionsArticle Views338Altmetric-Citations10LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (1 MB) Get e-Alertsclose Get e-Alerts
On Generalizing the Concept of Hypertext (1992)

Hypertext has quickly become an established paradigm in the design of information systems. The success of products in the software market, evident benefits as reported by users, and the flowering of related research activity all attest to the significance and staying power of hypertext-rich information systems. Although standard hypertext has a number of unquestioned benefits, the concept also has a number of well-known problems and limitations. This article reviews the main problems and limitations of basic (standard) hypertext that constrain the use of hypertext in practical applications. Further, this article presents and discusses our “generalization” of the basic hypertext concept, which we call generalized hypertext. These generalizations encompass, among other things, automatic creation of hypertext elements. Generalized hypertext promises to be more powerful than standard hypertext as well as less expensive to implement and maintain. To illustrate these concepts, we describe the implementation of a decision support system currently in use by the U.S. Coast Guard.
Investigation of Seawater Reverse Osmosis Fouling and Its Relationship To Pretreatment Type (2006)

Desalination of seawater using reverse osmosis (RO) technology is an important option available to water-scarce coastal regions. A major challenge to seawater reverse osmosis (SWRO) is membrane productivity decline due to fouling. Systematic studies in the area of SWRO fouling are lacking as compared to RO fouling by freshwater. The effect of the type of pretreatment employed ahead of the SWRO process has been recognized to be of critical importance in SWRO fouling. The objective of this study was to evaluate the effect of pretreatment on SWRO performance using bench scale experiments. The effect of different pretreatment strategies on SWRO flux decline was simulated using prefiltration of the SWRO feedwater using different filtration size ranges. The prefiltration size ranges used were selected to mimic the size fractions associated with different SWRO pretreatment processes. It was found that particulate matter greater than 1 microm (representing media filtration) caused most of the RO fouling. On the other hand, significant reduction in fouling was observed when membrane filtration was used (microfiltration represented by 0.1 microm prefiltration and ultrafiltration represented by 100 kDa prefiltration). There was no significant difference in flux decline between these two membrane filtration types. The lowest RO flux decline was observed when a tight ultrafiltration membrane (20 kDa) was used as prefiltration. The RO fouling observed was modeled using the gel layertheory, which could be used to satisfactorily describe fouling by different dissolved fractions of seawater. The observed SWRO fouling trends were confirmed using specially adapted attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy of the fouled membrane surface.
Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. (2000)

Betacellulin (BTC), a member of the epidermal growth factor family, is expressed predominantly in the human pancreas and induces the differentiation of a pancreatic acinar cell line (AR42J) into insulin-secreting cells, suggesting that BTC has a physiologically important role in the endocrine pancreas. In this study, we examined the in vivo effect of recombinant human BTC (rhBTC) on glucose intolerance and pancreatic morphology using a new mouse model with glucose intolerance induced by selective alloxan perfusion. RhBTC (1 microg/g body wt) or saline was injected subcutaneously every day from the day after alloxan treatment. The intraperitoneal glucose tolerance test revealed no difference between rhBTC-treated and rhBTC-untreated glucose-intolerant mice at 2-4 weeks. However, glucose tolerance was significantly improved and body weight was significantly increased in rhBTC-treated mice compared with untreated mice at 8 weeks. Islet-like cell clusters, consisting mainly of beta-cells, were increased in the pancreas and were localized in contact with the ductal lining cells and sometimes with acinar cells. In conclusion, administration of rhBTC improved glucose tolerance in this mouse model by increasing beta-cell volume, primarily through accelerated neogenesis from ductal lining cells.
Hydroxoiridium‐Catalyzed Hydroalkylation of Terminal Alkenes with Ureas by C(sp3)−H Bond Activation (2017)

Direct alkylation of a methyl group, on di- and trisubstituted ureas, with terminal alkenes by C(sp<sup>3</sup> )-H bond activation proceeded in the presence of a hydroxoiridium/bisphosphine catalyst to give high yields of the corresponding addition products. The hydroxoiridium/bisphosphine complex generates an amidoiridium intermediate by reaction with ureas having an N-H bond.
Growth hormone secretagogues in children with altered growth (1997)

A diagnostic test was devised to evaluate pituitary growth hormone (GH) secretory potential. GH secretory dynamics were assessed in children with and without GH deficiency. The GH response was measured to GH-releasing hormone (GHRH) and the GH-releasing peptide GHRP-2, administered sequentially. The mean (+/- SEM) peak GH response to GHRP-2 was 20.1 +/- 5.5, 63.6 +/- 24.9 and 42.2 +/- 4.3 micrograms/l for GH-deficient, slowly growing non-GH-deficient and control children, respectively (p < 0.02 and p < 0.05 for GH-deficient vs controls and slowly growing children, respectively). Corresponding values for area under the curve (AUC) were 995 +/- 371. 2460 +/- 953 and 1598 +/- 274 micrograms/l x minute. Peak GH (and AUC) responses to GHRH were 19.6 +/- 5.1 micrograms/l (924 +/- 232 micrograms/l x minute), 31.4 +/- 8.4 micrograms/l (1544 +/- 449 micrograms/l x minute) and 39.8 +/- 7.8 micrograms/l (2201 +/- 437 micrograms/l x minute) for the same three groups, respectively (p < 0.05 for peak GH in GH-deficient patients vs controls, and p < 0.02 and p < 0.01 for AUC in GH-deficient vs slowly growing children and controls, respectively). The ratio of the peak GH response to GHRP-2 and GHRH was similar in all three groups. As these secretagogues stimulate different aspects of hypothalamic function (i.e., they are functional complements), robust GH secretion in response to GHRH or GHRP could suggest adequate endogenous GHRP or GHRH, respectively. A poor response to either GH secretagogue administered individually could represent inadequacy of its endogenous complement. The integrity of functional pituitary elements could be differentiated from inadequate complements by administering both GH secretagogues simultaneously. Application of these principles should allow a better definition of the underlying disorder and provide the basis for therapeutic strategies for those patients with abnormal GH production and/or secretion.
A technology for high-performance single-crystal silicon-on-insulator transistors (1987)

A process for forming transistors and circuits in a thin single-crystal silicon film on a glass substrate is presented. The process involves the electrostatic bonding of a silicon wafer to glass and the subsequent thinning of the wafer using doping-sensitive etchants to retain only the epitaxial layer. NMOS transistors have shown channel mobilities of 640 cm <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sup> /V-s, while leakage currents have been measured at less than 10 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">-14</sup> A/µm.